Here, we exhaustively examined the influence of two frequent SORL1 mutations linked to either benign of severe autosomal dominant cases of AD on the amyloidogenic and non-amyloidogenic APP products, secretases expressions and activity and Aβ degradation processes. Here, APP is linked to Alzheimer disease.